{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"itm2b-amyloidosis","columns":[{"gene":"","key":"population-a5455b6a7bd421d97540","label":"ITM2B amyloidosis","mondoId":"MONDO:0018591","onsetQualifier":null,"originColumnKey":"MONDO:0018591/ORPHA:439254","originalViews":[{"key":"MONDO:0018591/ORPHA:439254","label":"ITM2B amyloidosis","scopeLabel":"ORPHA:439254","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0c022641446046562c8a33e7247cdb5b22000828467d5cea1739b0517da873b9","278e9422de855e6c8eb3f5ff043244ca7094d0a016be144490aae77291d3b434","861e00638b4ef2f515a04565964d91396f99724571323e8968c31e075bdcd9bb","b61434b85901fc0884172827266376bc0954ad46b8b4955680190ec25f5415cc","b63641ef9c2e2396f045593b57fa36d6cc9fe707acb820859e4b64d5f3824e8f","cc255fbeaafef0d88128145ff8083ef603e4b9b96fafed919ef9c6ced6f1488f","d4aed3f7e34fc8ede030a9349fb3396fc58cccf49f4e46a0a5741d3fc8523567","f227815ba1e36813203d02defcd004a3d7965831d0532923822ce47e2ae126b7"],"recordQualifiers":{},"scopeLabel":"ORPHA:439254","sourceIds":["ORPHA:439254"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a5455b6a7bd421d97540"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000518","HP:0011970","HP:0000726","HP:0000365","HP:0002352","HP:0002185","HP:0002073"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"orphanet":8}},"features":[{"hpoId":"HP:0000518","label":"Cataract","primary":true},{"hpoId":"HP:0011970","label":"Cerebral amyloid angiopathy","primary":true},{"hpoId":"HP:0000726","label":"Dementia","primary":true},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":true},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":true},{"hpoId":"HP:0002185","label":"Neurofibrillary tangles","primary":true},{"hpoId":"HP:0002073","label":"Progressive cerebellar ataxia","primary":true},{"hpoId":"HP:0001285","label":"Spastic tetraparesis","primary":false}],"ledeHtml":"A rare, neurodegenerative disease characterized by progressive dementia and ataxia, widespread cerebral amyloid angiopathy and parenchymal amyloid deposition. Two subtypes have been identified, ABri amyloidosis and ADan amyloidosis.","mondoId":"MONDO:0018591","node":{"canonicalSlug":"itm2b-amyloidosis","comparisons":[{"documentSha256":"a18bee1c1dcc2038557db2b5edc46275cfd315cd66afcb3bc1870f6168afaa41","key":"legacy-itm2b-amyloidosis","kind":"legacy","label":"ITM2B amyloidosis","memberIds":["MONDO:0018591"],"mondoId":"MONDO:0018591","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/itm2b-amyloidosis.a18bee1c1dcc2038557db2b5edc46275cfd315cd66afcb3bc1870f6168afaa41.json"},{"documentSha256":"f2ce26ec83a58c0f7fb9534a5454cda38cbfcf2bfb80f65ae3cd02dc6b9b8a20","key":"expanded-itm2b-amyloidosis","kind":"expanded","label":"ITM2B amyloidosis","memberIds":["MONDO:0007297","MONDO:0008306","MONDO:0018591"],"mondoId":"MONDO:0018591","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-f2ce26ec83a58c0f7fb9.f2ce26ec83a58c0f7fb9534a5454cda38cbfcf2bfb80f65ae3cd02dc6b9b8a20.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"ITM2B amyloidosis","originalSourceId":"ORPHA:439254","paragraphs":["A rare, neurodegenerative disease characterized by progressive dementia and ataxia, widespread cerebral amyloid angiopathy and parenchymal amyloid deposition. Two subtypes have been identified, ABri amyloidosis and ADan amyloidosis."],"rawAttribution":"ORPHA:439254","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:50:04Z","upstream":"ORPHA:439254","url":"https://rarediseases.info.nih.gov/diseases/17741"},"ownColumnKeys":["population-a5455b6a7bd421d97540"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary amyloidosis","mondoId":"MONDO:0018634","slug":"hereditary-amyloidosis"},{"kind":"parent","label":"inherited neurodegenerative disorder","mondoId":"MONDO:0024237","slug":"inherited-neurodegenerative-disorder"},{"kind":"child","label":"ADan amyloidosis","mondoId":"MONDO:0007297","slug":"adan-amyloidosis"},{"kind":"child","label":"ABri amyloidosis","mondoId":"MONDO:0008306","slug":"abri-amyloidosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0c022641446046562c8a33e7247cdb5b22000828467d5cea1739b0517da873b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"278e9422de855e6c8eb3f5ff043244ca7094d0a016be144490aae77291d3b434","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"861e00638b4ef2f515a04565964d91396f99724571323e8968c31e075bdcd9bb","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b61434b85901fc0884172827266376bc0954ad46b8b4955680190ec25f5415cc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b63641ef9c2e2396f045593b57fa36d6cc9fe707acb820859e4b64d5f3824e8f","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc255fbeaafef0d88128145ff8083ef603e4b9b96fafed919ef9c6ced6f1488f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002073","is_excluded":false,"label":"Progressive cerebellar ataxia","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d4aed3f7e34fc8ede030a9349fb3396fc58cccf49f4e46a0a5741d3fc8523567","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011970","is_excluded":false,"label":"Cerebral amyloid angiopathy","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f227815ba1e36813203d02defcd004a3d7965831d0532923822ce47e2ae126b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002185","is_excluded":false,"label":"Neurofibrillary tangles","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17741\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:439254</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, neurodegenerative disease characterized by progressive dementia and ataxia, widespread cerebral amyloid angiopathy and parenchymal amyloid deposition. Two subtypes have been identified, ABri amyloidosis and ADan amyloidosis.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17741\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"itm2b-amyloidosis","sourceDocuments":[{"name":"GARD: ITM2B amyloidosis","reviewed":null,"source_release":"2026-10-21T15:50:04Z","url":"https://rarediseases.info.nih.gov/diseases/17741"}],"sourceNote":"","synonyms":["familial cerebral amyloid angiopathy","ITM2B-related amyloidosis","ITM2B-related cerebral amyloid angiopathy"],"takeawayHtml":"","title":"ITM2B amyloidosis"},"schemaVersion":1}
